PureTech Health (PRTC) Common Equity: 2019-2024
- PureTech Health's Common Equity was N/A to $226.3 million in Q2 2024 from the same period last year, while for Jun 2024 it was $226.3 million, marking a year-over-year change of. This contributed to the annual value of $339.4 million for FY2023, which is 37.40% down from last year.
- According to the latest figures from Q2 2024, PureTech Health's Common Equity is $226.3 million, which was down 33.32% from $339.4 million recorded in Q4 2023.
- Over the past 5 years, PureTech Health's Common Equity peaked at $669.7 million during Q4 2020, and registered a low of $226.3 million during Q2 2024.
- Moreover, its 3-year median value for Common Equity was $339.4 million (2023), whereas its average is $369.3 million.
- As far as peak fluctuations go, PureTech Health's Common Equity climbed by 0.26% in 2020, and later plummeted by 37.40% in 2023.
- PureTech Health's Common Equity (Quarterly) stood at $669.7 million in 2020, then decreased by 11.38% to $593.5 million in 2021, then decreased by 8.64% to $542.2 million in 2022, then tumbled by 37.40% to $339.4 million in 2023, then reached $226.3 million in 2024.
- Its Common Equity stands at $226.3 million for Q2 2024, versus $339.4 million for Q4 2023 and $542.2 million for Q4 2022.
